MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Pancreatic Adenocarcinoma

  1. Home
  2. Diseases
  3. Pancreatic Adenocarcinoma
  4. Clinical Trials

Clinical Trials Related to Pancreatic Adenocarcinoma

Related studies linked through entity extraction aliases.

NCT04137536

A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE1

NCT03816358

Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE1

NCT03415854

Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)

Status
COMPLETED
Phase
PHASE2

NCT03138720

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Status
COMPLETED
Phase
PHASE2

NCT03033927

Predicting Effective Therapy in Pancreatic Cancer

Status
ACTIVE_NOT_RECRUITING
Phase
N/A

NCT02495896

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE1

NCT02072616

Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.

Status
TERMINATED
Phase
NA
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.